Published in Clin Endocrinol (Oxf) on September 01, 1994
Bone mineral density in estrogen-deficient young women. J Clin Endocrinol Metab (2009) 1.33
Bone microarchitecture is impaired in adolescent amenorrheic athletes compared with eumenorrheic athletes and nonathletic controls. J Clin Endocrinol Metab (2011) 1.11
Bone mineral density in professional female dancers. Br J Sports Med (1997) 0.98
Bone mineral density in young women with primary ovarian insufficiency: results of a three-year randomized controlled trial of physiological transdermal estradiol and testosterone replacement. J Clin Endocrinol Metab (2014) 0.95
The female athlete triad. Sports Health (2012) 0.91
Effect of oral contraceptives and hormone replacement therapy on bone mineral density in premenopausal and perimenopausal women: a systematic review. Br J Sports Med (2006) 0.90
Osteoporosis associated with antipsychotic treatment in schizophrenia. Int J Endocrinol (2013) 0.78
Sacral stress fracture in a female collegiate distance runner: a case report. J Athl Train (2000) 0.75
Hyperprolactinaemia and impotence. Clin Endocrinol (Oxf) (1978) 2.91
Hypersecretion of luteinising hormone, infertility, and miscarriage. Lancet (1990) 2.87
Tests of hypothalamic-pituitary-adrenal function in man. Q J Med (1969) 2.41
Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. BMJ (1988) 2.29
Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization. Clin Endocrinol (Oxf) (2001) 2.16
Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet (1986) 2.14
Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: a meta-analysis. Fertil Steril (2000) 2.08
Detection of antigen-antibody binding events with the atomic force microscope. Biochemistry (1997) 2.05
Cumulative conception and livebirth rates after in-vitro fertilisation. Lancet (1992) 2.01
Mathematical analysis of kinetics of radioligand assays: improved sensitivity obtained by delayed addition of labeled ligand. J Clin Endocrinol Metab (1971) 1.86
Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod (1995) 1.75
Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins. Lancet (1984) 1.71
Diagnosis, prevention and management of ovarian hyperstimulation syndrome. Br J Obstet Gynaecol (1995) 1.71
Kallmann's syndrome: is it always for life? Clin Endocrinol (Oxf) (1999) 1.68
Management of hyperprolactinaemic amenorrhoea. Br J Obstet Gynaecol (1977) 1.65
Incidence and significance of hyperprolactinaemia in women with amenorrhea. Clin Endocrinol (Oxf) (1975) 1.61
Hypersecretion of luteinising hormone: a significant cause of infertility and miscarriage. Br J Obstet Gynaecol (1993) 1.57
Comparison of intravenous albumin and transfer of fresh embryos with cryopreservation of all embryos for subsequent transfer in prevention of ovarian hyperstimulation syndrome. Fertil Steril (1996) 1.56
Comparison of natural with clomiphene citrate-stimulated cycles in in vitro fertilization: a prospective, randomized trial. Fertil Steril (1994) 1.55
Electron Microscopy of Staphylococcus aureus Treated with Tetracycline. Science (1962) 1.51
Polycystic ovaries are a common finding in untreated female to male transsexuals. Clin Endocrinol (Oxf) (1993) 1.51
Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin Endocrinol (Oxf) (1989) 1.48
A prospective study comparing unilateral and bilateral laparoscopic ovarian diathermy in women with the polycystic ovary syndrome. Fertil Steril (1994) 1.46
Ultrasound demonstration of increased frequency of functional ovarian cysts in women using progestogen-only oral contraception. Br J Obstet Gynaecol (1985) 1.44
Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol (1998) 1.43
The treatment of acromegaly with special reference to trans-sphenoidal hypophysectomy. Q J Med (1975) 1.40
Clinical and endocrine features of hyperprolactinaemic amenorrhoea. Clin Endocrinol (Oxf) (1976) 1.40
In-situ atomic force microscopy study of beta-amyloid fibrillization. J Mol Biol (2000) 1.40
Polycystic ovaries in patients with hypogonadotropic hypogonadism: similarity of ovarian response to gonadotropin stimulation in patients with polycystic ovarian syndrome. Fertil Steril (1992) 1.40
The outcome of hypophysectomy for prolactinomas in the era of dopamine agonist therapy. Clin Endocrinol (Oxf) (1996) 1.40
The neuroradiology of Kallmann's syndrome: a genotypic and phenotypic analysis. J Clin Endocrinol Metab (1996) 1.38
Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers. Pharm Res (1994) 1.37
Predictors of ovarian reserve in young women with breast cancer. Br J Cancer (2007) 1.35
Surface plasmon resonance analysis of dynamic biological interactions with biomaterials. Biomaterials (2000) 1.33
A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization. Hum Reprod (1993) 1.33
Radioimmunoassay and saturation analysis. Pituitary and placental glycopeptide hormones. Br Med Bull (1974) 1.27
Growth hormone facilitates ovulation induction by gonadotrophins. Clin Endocrinol (Oxf) (1988) 1.25
Characterization of idiopathic premature ovarian failure. Fertil Steril (1996) 1.24
Biodegradable microparticles as controlled release antigen delivery systems. Immunology (1991) 1.24
Outcome of pregnancy in underweight women after spontaneous and induced ovulation. Br Med J (Clin Res Ed) (1988) 1.22
Plasma 11-hydroxycorticosteroid and growth hormone levels in acute medical illnesses. Br Med J (1969) 1.21
Relationship of ovarian stromal volume to serum androgen concentrations in patients with polycystic ovary syndrome. Hum Reprod (1998) 1.21
Characterization of the surfaces generated by liposome binding to the modified dextran matrix of a surface plasmon resonance sensor chip. Anal Biochem (2000) 1.15
Post-"pill" amenorrhoea--cause or coincidence? Br Med J (1977) 1.15
Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin. Hum Reprod (1993) 1.14
Ovarian ultrasound assessment in normal children, idiopathic precocious puberty, and during low dose pulsatile gonadotrophin releasing hormone treatment of hypogonadotrophic hypogonadism. Arch Dis Child (1985) 1.13
Reproductive and endocrine function after surgical treatment of bilateral crytorchidism. Lancet (1974) 1.13
The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization. Fertil Steril (1992) 1.12
Force-induced melting of a short DNA double helix. Eur Biophys J (2001) 1.11
Creutzfeldt-Jakob disease in recipients of human growth hormone in the United Kingdom: a clinical and radiographic study. Q J Med (1992) 1.11
Microencapsulation using emulsification/solvent evaporation: an overview of techniques and applications. Crit Rev Ther Drug Carrier Syst (1990) 1.11
Bone mineral loss in young women with amenorrhoea. BMJ (1990) 1.11
A prospective randomized study of the optimum timing of human chorionic gonadotropin administration after pituitary desensitization in in vitro fertilization. Fertil Steril (1992) 1.09
In-vitro fertilization and the ovarian hyperstimulation syndrome. Hum Reprod (1992) 1.08
Preparation of sub-100 nm human serum albumin nanospheres using a pH-coacervation method. J Drug Target (1993) 1.07
Spontaneous pregnancy in a patient with hypergonadotrophic ovarian failure. Br J Obstet Gynaecol (1979) 1.07
Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol (Oxf) (1992) 1.07
Amenorrhoea and loss of weight. Br J Obstet Gynaecol (1977) 1.07
Interactions of 3T3 fibroblasts and endothelial cells with defined pore features. J Biomed Mater Res (2002) 1.06
Relation between plasma oestrone and oestradiol and climacteric symptoms. Lancet (1978) 1.06
The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives. Clin Endocrinol (Oxf) (1990) 1.06
Investigation and treatment of amenorrhoea resulting in normal fertility. Br Med J (1979) 1.05
Induction of puberty by pulsatile gonadotropin releasing hormone. Lancet (1987) 1.05
Synthesis and characterisation of a degradable poly(lactic acid)-poly(ethylene glycol) copolymer with biotinylated end groups. Biomacromolecules (2001) 1.05
Influence of carbon dioxide on the surface characteristics and adherence potential of coagulase-negative staphylococci. J Clin Microbiol (1990) 1.03
Therapy-orientated diagnosis of secondary amenorrhoea. Horm Res (1975) 1.02
Coronary heart disease in relation to age, sex, and the menopause. Br Med J (1978) 1.02
A miniature infuser for the pulsatile administration of LHRH. J Biomed Eng (1984) 1.02
Testicular function following irradiation of the human prepubertal testis. Clin Endocrinol (Oxf) (1978) 1.02
Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients. Fertil Steril (1991) 1.02
Luteinizing hormone: its role, mechanism of action, and detrimental effects when hypersecreted during the follicular phase. Fertil Steril (1993) 1.01
Prolactin concentrations in patients with breast cancer. Br Med J (1974) 1.01
Structure and behavior in hydrophilic matrix sustained release dosage forms: 4. Studies of water mobility and diffusion coefficients in the gel layer of HPMC tablets using NMR imaging. Pharm Res (1996) 1.01
Laparoscopic ovarian diathermy in the management of anovulatory infertility in women with polycystic ovaries: endocrine changes and clinical outcome. Fertil Steril (1990) 1.01
Abnormal electromyographic activity of the urethral sphincter, voiding dysfunction, and polycystic ovaries: a new syndrome? BMJ (1988) 1.01
In vitro assessment of bacterial adhesion to Hydromer-coated cerebrospinal fluid shunts. Biomaterials (1993) 1.01
In situ observation of streptavidin-biotin binding on an immunoassay well surface using an atomic force microscope. FEBS Lett (1996) 1.00
Spatially controlled cell engineering on biodegradable polymer surfaces. FASEB J (1998) 1.00
Control of staphylococcal adhesion to polystyrene surfaces by polymer surface modification with surfactants. Biomaterials (1992) 1.00
Osteopenia as a feature of the androgen insensitivity syndrome. Clin Endocrinol (Oxf) (1995) 1.00
Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries. Hum Reprod (1998) 0.99
For and against: The male menopause--does it exist? BMJ (2000) 0.99
The prevalence of polycystic ovaries in women with type 2 diabetes mellitus. Clin Endocrinol (Oxf) (2000) 0.99
Measuring and visualizing single molecular interactions in biology. Biochem Soc Trans (2003) 0.99
Resistance to nonspecific protein adsorption by poly(vinyl alcohol) thin films adsorbed to a poly(styrene) support matrix studied using surface plasmon resonance. Anal Chem (2001) 0.99
Cumulative conception and live-birth rates after in vitro fertilization with and without the use of long, short, and ultrashort regimens of the gonadotropin-releasing hormone agonist buserelin. Am J Obstet Gynecol (1994) 0.98
Familial polycystic ovaries: a genetic disease? Clin Endocrinol (Oxf) (1988) 0.98
Pulsatile luteinizing hormone-releasing hormone therapy in women with polycystic ovary syndrome. Fertil Steril (1988) 0.96
Electrostatic interactions observed when imaging proteins with the atomic force microscope. Ultramicroscopy (2003) 0.96
Prolactin concentrations in patients with acromegaly: clinical significance and response to surgery. Clin Endocrinol (Oxf) (1976) 0.95
Recent advances in the management of patients with amenorrhoea. Clin Obstet Gynaecol (1985) 0.94
Competitive protein adsorption as observed by surface plasmon resonance. Biomaterials (1999) 0.93
Serum LH and FSH during sexual maturation in the male rat: effect of castration and cryptorchidism. Endocrinology (1971) 0.93
Characterization of protein-resistant dextran monolayers. Biomaterials (2000) 0.93
Subclinical cardiac dysfunction in acromegaly: evidence for a specific disease of heart muscle. Br Heart J (1989) 0.93
A comparison of the adhesion of mammalian cells and Staphylococcus epidermidis on fibronectin-modified polymer surfaces. J Biomed Mater Res (2001) 0.92
Surface plasmon resonance for real time in situ analysis of protein adsorption to polymer surfaces. Biomaterials (1997) 0.92
Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome. Clin Endocrinol (Oxf) (1996) 0.92